NOXXON to Attend the German Fall Conference on September 6 & 7, 2021
Retrieved on:
Wednesday, August 25, 2021
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, NOX-A12, Terminology, Merck Sharp & Dohme Federal Credit Union, Immune system, Communication, GLORIA, Brain, Radiation, MGMT, Tumor microenvironment, ESMO, TME, Safety, Patient, Pembrolizumab, Pancreatic cancer, Neoplasm, German Autumn, Pharmaceutical industry, Medical imaging, NOXXON, the GLORIA Study, the OPTIMUS Study, NOXXON, THE GLORIA STUDY, THE OPTIMUS STUDY
The capital market conference for small and mid-cap companies organized by Equity Forum will take place in the form of virtual one-on-one meetings.
Key Points:
- The capital market conference for small and mid-cap companies organized by Equity Forum will take place in the form of virtual one-on-one meetings.
- The conference aims at bringing together public company representatives across sectors with investors, analysts, financial journalists, intermediaries and financial industry experts.
- NOXXONs CEO, Aram Mangasarian, will be available for meetings on both conference days.
- To schedule a meeting please contact the conference organizer or send an email to [email protected] .